Moneycontrol PRO
HomeNewsBusinessEconomyRK Vats gets additional charge of NPPA chairmanship

RK Vats gets additional charge of NPPA chairmanship

Vats holds multiple positions including that of Director General (DG) of Central Government Health Scheme (CGHS). He is also the Chairman and Managing Director of HLL Lifecare Limited.

April 07, 2018 / 14:16 IST

The Union government appointed Rakesh Kumar Vats as the chairman of the National Pharmaceutical Pricing Authority (NPPA) with immediate effect.

The chairmanship of the Indian drug price regulator will be an additional charge for Vats, who is the additional secretary in the Ministry of Health and Family Welfare. Vats belongs to the 1986 West Bengal Indian Administrative Services (IAS) cadre.

He holds multiple positions including that of Director General (DG) of Central Government Health Scheme (CGHS), is the Chairman and Managing Director (CMD) of HLL Lifecare Limited (HLL), a public sector enterprise under Union Health Ministry that makes condoms, vaccines, medical consumables and diagnostic kits.

“The Competent Authority has approved the assignment of the additional charge of the post of Chairman, National Pharmaceutical Pricing Authority, Ministry of Chemicals and Fertilizers to Shri Rakesh Kumar Vats, IAS, Additional Secretary, Ministry of Health & Family Welfare with immediate effect and until further orders,” said a statement from PK Tripathi, Secretary, Appointments Committee of the Cabinet and Establishment Officer, Department of Personnel and Training.

The post of NPPA chairman fell vacant after the government transferred Bhupendra Singh last month to head the National Authority of Chemical Weapons Convention (NACWC).

The chairman of NPPA assumed significance under Singh after the authority took steps to rein in profiteering by companies by bringing in more drug formulations under the ambit of Drug Price Control Order and capping prices of stents and knee implants.

NPPA has been fighting several court cases to recover dues worth hundreds of crore rupees from pharma companies for violating DPCO.

Sources told Moneycontrol that NPPA without a chairman has put itself in serious risk of losing some of these cases.

Although healthcare activists welcomed the appointment, they were disappointed about handing over such an important charge to a bureaucrat whose hands are already tied-up with several other important responsibilities.

Viswanath Pilla
Viswanath Pilla is a business journalist with 14 years of reporting experience. Based in Mumbai, Pilla covers pharma, healthcare and infrastructure sectors for Moneycontrol.
first published: Apr 6, 2018 09:20 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347